137
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Treatment Sequencing Patterns in Patients with Metastatic Urothelial Cancer Treated in the Community Practice Setting in the United States: SPEAR-Bladder (Study informing treatment Pathway dEcision in bladder cAnceR)

, , , , , , , ORCID Icon & show all
Pages 645-656 | Published online: 05 Nov 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Makito Miyake, Nobutaka Nishimura, Takuto Shimizu, Mikiko Ohnishi, Masaomi Kuwada, Yoshitaka Itami, Takeshi Inoue, Kenta Ohnishi, Yoshihiro Matsumoto, Takanori Yoshida, Yoshihiro Tatsumi, Masatake Shinohara, Shunta Hori, Yosuke Morizawa, Daisuke Gotoh, Yasushi Nakai, Satoshi Anai, Kazumasa Torimoto, Katsuya Aoki, Tomomi Fujii, Nobumichi Tanaka & Kiyohide Fujimoto. (2022) Significant Improvement of Prognosis After the Advent of Immune Checkpoint Inhibitors in Patients with Advanced, Unresectable, or Metastatic Urothelial Carcinoma: A Propensity Score Matching and Inverse Probability of Treatment Weighting Analysis on Real-World Data. Cancer Management and Research 14, pages 623-635.
Read now

Articles from other publishers (2)

Daniel M. Geynisman, Edward Broughton, Yi Hao, Ying Zhang, Trong Le & Stephen Huo. (2022) Real-world treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in the United States. Urologic Oncology: Seminars and Original Investigations 40:5, pages 195.e1-195.e11.
Crossref
Petros Grivas, Neeraj Agarwal, Sumanta Pal, Arash Rezazadeh Kalebasty, Srikala S. Sridhar, Jodi Smith, Geeta Devgan, Cora N. Sternberg & Joaquim Bellmunt. (2021) Avelumab first-line maintenance in locally advanced or metastatic urothelial carcinoma: Applying clinical trial findings to clinical practice. Cancer Treatment Reviews 97, pages 102187.
Crossref